Mismatch repair cancer syndrome

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
0 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Phase I: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase I

2 trials
  • Beigene Ltd. Commercial
    IMP not specified
    2023-503996-38-00 1 country 2025 n=60
    Ended
  • Novartis Pharma AG Commercial
    IMP not specified
    2022-502314-93-00 7 countries 2024 n=184
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Beigene Ltd. Commercial 1 Phase I 0
Novartis Pharma AG Commercial 1 Phase I 0
New trials by year
2024
1
2025
1
← All indication landscapes